Display Settings:

Format

Send to:

Choose Destination
Clin Microbiol Rev. 2007 Oct;20(4):535-49.

Type III secretion systems and disease.

Author information

  • 1Michael Smith Laboratories, UBC, 301-2185 East Mall, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z4. bfinlay@interchange.ubc.ca

Abstract

Type III secretion systems (T3SSs) are complex bacterial structures that provide gram-negative pathogens with a unique virulence mechanism enabling them to inject bacterial effector proteins directly into the host cell cytoplasm, bypassing the extracellular milieu. Although the effector proteins vary among different T3SS pathogens, common pathogenic mechanisms emerge, including interference with the host cell cytoskeleton to promote attachment and invasion, interference with cellular trafficking processes, cytotoxicity and barrier dysfunction, and immune system subversion. The activity of the T3SSs correlates closely with infection progression and outcome, both in animal models and in human infection. Therefore, to facilitate patient care and improve outcomes, it is important to understand the T3SS-mediated virulence processes and to target T3SSs in therapeutic and prophylactic development efforts.

PMID:
17934073
[PubMed - indexed for MEDLINE]
PMCID:
PMC2176049
Free PMC Article

Images from this publication.See all images (2)Free text

FIG. 1.
FIG. 2.
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk